4.3 Article Proceedings Paper

Prehabilitation in thoracic surgery

Journal

JOURNAL OF THORACIC DISEASE
Volume 10, Issue -, Pages S2593-S2600

Publisher

AME PUBL CO
DOI: 10.21037/jtd.2018.08.18

Keywords

Prehabilitation; lung cancer; lung resection; enhanced recovery after surgery (ERAS); fast track; respiratory physiotherapy; rehabilitation; preconditioning

Ask authors/readers for more resources

Surgical resection remains the best treatment option for patients with early stage of non-small cell lung cancer (NSCLC). However, it may be responsible of postoperative complication and mortality, especially in patients with impaired pulmonary function. Enhanced recovery after surgery (ERAS) programs have been focused mainly in minimal invasive surgery approach during lung resection and respiratory rehabilitation after surgery. Preoperative exercise-based intervention (prehabilitation) has demonstrated reduction of morbi-mortality in other surgeries but in thoracic surgery continues to be under discussion. Cardio-pulmonary exercise test (CPET) is the gold standard technique to predict postoperative morbimortality. The implementation of a preoperative respiratory rehabilitation could optimize patient's physical capacity before surgery and improve outcomes and enhance recovery. The aim of this systematic review of the literature is to identify the effectiveness and safety of prehabilitation programs in thoracic surgery, the type of exercise and its duration, and the group of patients with best benefit. Prehabilitation is a safe intervention without side effects in patients. High-intensity interval training (HIT) with duration of 2 to 6 weeks seems to be the best exercise programme in a prehabilitation intervention but it exists heterogeneity in terms of intensity and duration. Prehabilitation increase exercise capacity and significantly enhances pulmonary function. But the reduction of postoperative complication and mortality has not been clearly demonstrated. Different criteria selection, type of intervention and small sample size, in addition to no randomization, could justify disparate results. It seems that not all patients can benefit from prehabilitation and it could be indicated only in patients with impaired lung function. Further randomized clinical trials with enough patients, correct duration of HIT (2 to 6 weeks) and focused in COPD patients are needed to clarify the suitability of prehabilitation. Meanwhile, safety of prehabilitation and good results of some studies support this intervention in high-risk patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Respiratory System

VATS Lobectomy Morbidity and Mortality is Lower in Patients with the Same ppoDLCO: Analysis of the Database of the Spanish Video-Assisted Thoracic Surgery Group

Borja Aguinagalde, Asier Insausti, Iker Lopez, Laura Sanchez, Sergio Bolufer, Raul Embun

Summary: The study indicates that for major resections, patients undergoing VATS surgery have lower mortality and morbidity rates compared to open surgery. Lower ppoDLCO values significantly affect the risk of thoracotomy compared to VATS surgery.

ARCHIVOS DE BRONCONEUMOLOGIA (2021)

Article Critical Care Medicine

Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

Ana Jaureguizar, David Jimenez, Behnood Bikdeli, Pedro Ruiz-Artacho, Alfonso Muriel, Victor Tapson, Raquel Lopez-Reyes, Beatriz Valero, Gili Kenet, Manuel Monreal

Summary: This study investigated the association between heart rate and pulmonary embolism outcomes and found that a higher heart rate is associated with increased all-cause and PE-related mortality. Modifying the heart rate cutoff in the simplified Pulmonary Embolism Severity Index (sPESI) and the Bova score can improve the prognostication of patients with PE.

CHEST (2022)

Article Critical Care Medicine

Anticoagulation strategies and risk of bleeding events in critically ill COVID-19 patients

C. Gabara, B. Solarat, P. Castro, S. Fernandez, J. R. Badia, D. Toapanta, S. Schulman, J. C. Reverter, A. Soriano, J. Moises, J. Aibar

Summary: This study evaluated the rates of thrombosis, bleeding, and mortality in critically ill COVID-19 patients receiving different anticoagulant doses. The study found that bleeding events were more frequent in the intermediate and therapeutic dose groups, but there were no significant differences in thrombosis and mortality rates.

MEDICINA INTENSIVA (2023)

Article Medicine, General & Internal

Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism

Diego Martinez-Urbistondo, Rocio G. de la Garza, Paula Villares-Fernandez, Carme Font, Sebastian Schellong, Juan Jose Lopez-Nunez, Aida Gil-Diaz, Maria del Carmen Diaz-Pedroche, Jana Hirmerova, Manuel Monreal

Summary: The study examined the relationship between elevated liver enzymes or FIB-4 levels and outcomes in VTE patients receiving anticoagulation therapy. Findings suggest that elevated liver enzymes were associated with higher mortality risk, while FIB-4 levels > 2.67 points were linked to increased major bleeding risk. Evaluating liver enzymes and FIB-4 index in VTE patients without liver disease may offer additional insights into the risk of major bleeding or death during anticoagulation therapy.

INTERNAL AND EMERGENCY MEDICINE (2022)

Letter Respiratory System

Histology Study of Postmortem Lung Biopsies in Patients With Covid-19 Pneumonia

Jacobo Sellares, Carlos Guerrero, Daniel Martinez, Mariana Benegas, Sandra Cuerpo, Fernanda Hernandez-Gonzalez, Alejandra Libreros, Rudith Guzman, Angela Guirao, Marc Boada, David Sanchez-Lorente, Nuria Albacar, Leandro Grando, Pablo Paglialunga, Francisco Javier Garcia, Rosa Faner, Alvar Agusti, Oriol Sibila, Marcelo Sanchez, Laureano Molins, Jose Ramirez

ARCHIVOS DE BRONCONEUMOLOGIA (2022)

Article Respiratory System

Surgical Risk Following Anatomic Lung Resection in Thoracic Surgery: A Prediction Model Derived From a Spanish Multicenter Database

David Gomez de Antonio, Silvana Crowley Carrasco, Alejandra Romero Roman, Ana Royuela, Alvaro Sanchez Calle, Carme Obiols Fornell, Sergi Call Caja, Raul Embun, Inigo Royo, Jose Luis Recuero, Alberto Cabanero, Nicolas Moreno, Sergio Bolufer, Miguel Congregado, Marcelo F. Jimenez, Borja Aguinagalde, Sergio Amor-Alonso, Miguel Jesus Arraras, Ana Isabel Blanco Orozco, Marc Boada, Isabel Cal, Angel Cilleruelo Ramos, Elena Fernandez-Martin, Santiago Garcia-Barajas, Maria Dolores Garcia-Jimenez, Jose Maria Garcia-Prim, Jose Alberto Garcia-Salcedo, Juan Jose Gelbenzu-Zazpe, Carlos Fernando Giraldo-Ospina, Maria Teresa Gomez Hernandez, Jorge Hernandez, Jennifer D. Illana Wolf, Alberto Jauregui Abularach, Unai Jimenez, Iker Lopez Sanz, Nestor J. Martinez-Hernandez, Elisabeth Martinez-Tellez, Lucia Milla Collado, Roberto Mongil Poce, Francisco Javier Moradiellos-Diez, Ramon Moreno-Basalobre, Sergio B. Moreno Merino, Florencio Quero-Valenzuela, Maria Elena Ramirez-Gil, Ricard Ramos-Izquierdo, Eduardo Rivo, Alberto Rodriguez-Fuster, Rafael Rojo-Marcos, David Sanchez-Lorente, Laura Sanchez Moreno, Carlos Simon, Juan Carlos Trujillo-Reyes, Cipriano Lopez Garcia, Juan Jose Fibla Alfara, Julio Sesma Romero, Florentino Hernando Trancho

Summary: The aim of this study was to develop a surgical risk prediction model for patients undergoing anatomic lung resections. By analyzing a large dataset, the researchers identified relevant variables and developed a simple and effective model. This model can assist doctors in assessing the risk for patients undergoing surgery.

ARCHIVOS DE BRONCONEUMOLOGIA (2022)

Article Cardiac & Cardiovascular Systems

External validation of the European Society of Thoracic Surgeons morbidity and mortality risk models

David Gomez de Antonio, Silvana Crowley Carrasco, Alejandra Romero Roman, Ana Royuela, Mariana Gil Barturen, Carme Obiols, Sergi Call, Inigo Royo, Jose Luis Recuero, Alberto Cabanero, Nicolas Moreno, Raul Embun

Summary: The external validation of Eurolung 1 and Eurolung 2 was conducted in a multicentre national database. Eurolung 1 showed suboptimal calibration and lower discrimination, while Eurolung 2 exhibited good calibration and higher discrimination. Therefore, Eurolung 2 seems to be applicable to other anatomic lung-resected patients, while Eurolung 1 lacks generalizability for new patients.

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2022)

Article Surgery

Results in mediastinal lymph node staging of surgical lung cancer: Data from the prospective cohort of the Spanish Video-Assisted Thoracic Surgery Group

Iker Lopez, Borja Aguinagalde, Iratxe Urreta, Inigo Royo, Sergio Bolufer, Laura Sanchez, Jon Zabaleta, Arantza Fernandez-Monge, Jose Luis Recuero, Julio Sesma, Sergio Amor, Francisco Javier Moradiellos, Miguel Jesus Arraras, Ana Isabel Blanco, Marc Boada, David Sanchez, Alberto Cabanero, Nicolas Moreno, Isabel Cal, Ramon Moreno, Angel Cilleruelo, Silvana Crowley, David Gomez, Elena Fernandez, Florentino Hernando, Santiago Garcia, Cipriano Lopez, Maria Dolores Garcia, Jose Maria Garcia, Jose Eduardo Rivo, Jose Alberto Garcia, Juan Jose Gelbenzu, Maria Elena Ramirez, Carlos Fernando Giraldo, Roberto Mongil, Maria Teresa Gomez, Marcelo Jimenez, Jorge Henandez, Juan Jose Fibla, Jennifer Illana, Alberto Jauregui, Unai Jimenez, Rafael Rojo, Nestor J. Martinez, Elisabeth Martinez, Juan Carlos Trujillo, Lucia Milla, Sergio B. Moreno, Miguel Congregado, Carme Obiols, Sergi Call, Florencio Quero, Ricard Ramos, Alberto Rodriguez, Carlos Maria Simon, Raul Embun

Summary: The study aimed to assess the diagnostic performance of combined CT and PET in mediastinal staging of surgical lung cancer. The overall success rate of CT and PET was 82.9%, with a high negative predictive value. Tumors larger than 3 cm and higher mediastinal SUVmax were associated with lower success rates, while VATS approach was associated with higher success rates. The risk of unexpected pN2 increased with certain risk factors but did not vary significantly with invasive testing.

CIRUGIA ESPANOLA (2023)

Article Biochemistry & Molecular Biology

Characterization of the MicroRNA Cargo of Extracellular Vesicles Isolated from a Pulmonary Tumor-Draining Vein Identifies miR-203a-3p as a Relapse Biomarker for Resected Non-Small Cell Lung Cancer

Bing Han, Laureano Molins, Yangyi He, Nuria Vinolas, David Sanchez-Lorente, Marc Boada, Angela Guirao, Tania Diaz, Daniel Martinez, Jose Ramirez, Jorge Moises, Melissa Acosta-Plasencia, Mariano Monzo, Ramon M. Marrades, Alfons Navarro

Summary: By analyzing the cargo of extracellular vesicles (EVs) from the tumor-draining vein of the lung, researchers have identified a promising new biomarker (EV-miR-203a-3p) for predicting post-surgical relapse in patients with non-small cell lung cancer (NSCLC).

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Respiratory System

EBUS-TBNA in Extrathoracic Malignancies: Diagnostic and Prognostic Implications

Roberto Martin-Deleon, Belen Solarat, Jorge Moises, Carmen M. Lucena, Ainhoa Fontana, Ramon M. Marrades, Carles Agusti

Summary: The study aimed to assess the diagnostic yield and prognostic significance of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in patients with extrathoracic malignancies (EM) and abnormal mediastinal lymph nodes (MLN). The results showed that EBUS-TBNA had a high diagnostic yield in these patients, although the negative predictive value was lower in patients with head and neck tumors. Neoplastic MLN detected by EBUS-TBNA had prognostic implications in terms of overall survival and cancer-specific survival.
Article Respiratory System

Preoperative localization of lung nodules: a comparative analysis of hookwire and radio-guided procedures

Ivan Vollmer, Alfredo Paez-Carpio, David Sanchez-Lorente, Marc Boada, Daniel Martinez, Marcelo Sanchez, Nuria Sanchez-Izquierdo, Marta Tormo-Ratera, Jordi Ribera-Perianes, Sergi Vidal-Sicart, Enrique Carrero-Cardenal, Pilar Paredes

Summary: This study compared preoperative lung nodule localization using hookwire and radiotracer injection (ROLL). The ROLL technique was found to be safer and tended to result in smaller resection samples compared to hookwire localization.

JOURNAL OF THORACIC DISEASE (2022)

Article Hematology

Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

Javier Trujillo-Santos, Dominique Farge-Bancel, Jose Maria Pedrajas, Covadonga Gomez-Cuervo, Aitor Ballaz, Andrei Braester, Isabelle Mahe, Aurora Villalobos, Jose Antonio Porras, Manuel Monreal

Summary: The RIETECAT study compared the long-term effectiveness and safety of enoxaparin with dalteparin or tinzaparin for the secondary prevention of VTE in adults with active cancer. The study found that over a 6-month period, there were limited differences in VTE recurrences, mortality rate, and major bleeding between the two groups. Propensity score matching analysis confirmed these findings.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2022)

Article Respiratory System

Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge

Oriol Sibila, Lidia Perea, Nuria Albacar, Jorge Moises, Tamara Cruz, Nuria Mendoza, Belen Solarat, Gemma Lledo, Gerard Espinosa, Joan Albert Barbera, Joan Ramon Badia, Alvar Agusti, Jacobo Sellares, Rosa Faner

Summary: The study found that about 60% of COVID-19 survivors had reduced DLCO 6 months after discharge, mainly in those over 60 years old, with a history of smoking, hypertension, severe COVID-19 experience, and persistent dyspnea after discharge. In addition, patients with reduced DLCO had higher levels of epithelial and endothelial markers.

RESPIRATORY RESEARCH (2022)

Meeting Abstract Oncology

Pathological response after neoadjuvant chemotherapy versus chemoradiotherapy in stage III NSCLC

D. Munoz Guglielmetti, D. Sanchez, R. Reyes, M. Boada, J. Mases, M. Molla, F. Casas

RADIOTHERAPY AND ONCOLOGY (2021)

No Data Available